Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
There is no need to see a specialist first
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026
The rate-limiting enzyme of glycogen synthesis and the principal enzyme responsible for myocardial energy reserve maintenance were also upregulated, as was the proteasomal process by which the respirasome is recycled to maintain its functionality
The general rule is to apply products from the thinnest to the thickest consistency, and from water-based to oil-based formulations
US$ 22.65
US$ 21.54
US$ 21.67
US$ 26.17
US$ 26.44
